logo
Select company
Select metric
$ 3.88MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
37
Sector
75
Industry
90
History
100
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.32M$ 1.55M$ 3.88M
3/31/2025$ 2.35M$ -5.3M$ -2.95M
12/31/2024$ 2.49M$ -11.1M$ -8.61M
9/30/2024$ 2.63M$ -27.46M$ -24.84M
6/30/2024$ 2.77M$ -47.62M$ -44.85M
3/31/2024$ 2.87M$ -80.45M$ -77.58M
12/31/2023$ 2.9M$ -110.06M$ -107.16M
9/30/2023$ 2.98M$ -118.87M$ -115.89M
6/30/2023$ 2.95M$ -135.77M$ -132.81M
3/31/2023$ 2.89M$ -150.07M$ -147.18M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -226M.
  • Over the past 5 years, HERON THERAPEUTICS INC's average EBITDA has been $ -142.63M.
  • The median EBITDA for HERON THERAPEUTICS INC during this period was $ -162.74M
  • HERON THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 3.88M.
  • The lowest EBITDA recorded by HERON THERAPEUTICS INC in the same timeframe $ -232.92M

HERON THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
GLUE : MONTE ROSA THERAPEUTICS INC $ 36.76MCHRS : COHERUS ONCOLOGY INC $ 200.92MTRDA : ENTRADA THERAPEUTICS INC $ -73MMGNX : MACROGENICS INC $ -28.01MVNDA : VANDA PHARMACEUTICALS INC $ -77.06MAGEN : AGENUS INC $ -69.99MIGMS : IGM BIOSCIENCES INC $ -41.96MOSUR : ORASURE TECHNOLOGIES INC $ -37.18MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -72.27MALEC : ALECTOR INC $ -105.9M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] + DepAmor [ $ 2.7M ]
(=) EBITDA [ $ -226M ]

HRTX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -232.92M

Minimum

Jun 30, 2021

$ 3.88M

Maximum

Jun 30, 2025

$ -142.63M

Average

$ -162.74M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M